Literature DB >> 8046336

Interleukin 1 beta propeptide is detected intracellularly and extracellularly when human monocytes are stimulated with LPS in vitro.

G C Higgins1, J L Foster, A E Postlethwaite.   

Abstract

Human interleukin 1 beta (IL-1 beta) is synthesized as an inactive precursor that is cleaved by IL-1 converting enzyme (ICE) between Asp116 and Ala117 to form COOH-terminal mature IL-1 beta and NH2-terminal IL-1 beta propeptide. Little is known about the fate of the NH2-terminal cleavage product. In this study, human recombinant (hr)IL-1 beta propeptide (amino acids 2-116) was produced and used to prepare specific antibodies which do not recognize mature human IL-1 beta. These anti-propeptide antibodies were used for immunoprecipitation of biosynthetically labeled proteins from lipopolysaccharide-stimulated human monocytes. Analysis of immunoprecipitates by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and fluorography revealed that these antibodies recognize precursor IL-1 beta and two unique proteins: one migrating at 17.5 kD and one at 14 kD. The larger of these two proteins has a migration nearly identical to that of the recombinant IL-1 beta propeptide, and most likely represents naturally derived propeptide. The protein migrating at 14 kD may result from a second cleavage by ICE, between Asp27 and Gly28. These proteins accumulate intracellularly and extracellularly during pulse-chase experiments, and therefore represent stable products of precursor IL-1 beta cleavage.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8046336      PMCID: PMC2191596          DOI: 10.1084/jem.180.2.607

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  Sequence determinants of cytosolic N-terminal protein processing.

Authors:  C Flinta; B Persson; H Jörnvall; G von Heijne
Journal:  Eur J Biochem       Date:  1986-01-02

2.  Cloning, sequence, and expression of the Drosophila cAMP-dependent protein kinase catalytic subunit gene.

Authors:  J L Foster; G C Higgins; F R Jackson
Journal:  J Biol Chem       Date:  1988-02-05       Impact factor: 5.157

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs.

Authors:  C J March; B Mosley; A Larsen; D P Cerretti; G Braedt; V Price; S Gillis; C S Henney; S R Kronheim; K Grabstein
Journal:  Nature       Date:  1985 Jun 20-26       Impact factor: 49.962

5.  Nucleotide sequence of human monocyte interleukin 1 precursor cDNA.

Authors:  P E Auron; A C Webb; L J Rosenwasser; S F Mucci; A Rich; S M Wolff; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

6.  Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor.

Authors:  R A Black; S R Kronheim; M Cantrell; M C Deeley; C J March; K S Prickett; J Wignall; P J Conlon; D Cosman; T P Hopp
Journal:  J Biol Chem       Date:  1988-07-05       Impact factor: 5.157

7.  Antibodies to interleukin-1 raised with synthetic peptides: identification of external sites and analysis of interleukin-1 synthesis in stimulated human peripheral blood monocytes.

Authors:  R Bomford; E Abdulla; C Hughes-Jenkins; D Simpkin; J Schmidt
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

8.  The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor.

Authors:  B Mosley; D L Urdal; K S Prickett; A Larsen; D Cosman; P J Conlon; S Gillis; S K Dower
Journal:  J Biol Chem       Date:  1987-03-05       Impact factor: 5.157

9.  Post-transcriptional inhibition of collagen and fibronectin synthesis by a synthetic homolog of a portion of the carboxyl-terminal propeptide of human type I collagen.

Authors:  R S Aycock; R Raghow; G P Stricklin; J M Seyer; A H Kang
Journal:  J Biol Chem       Date:  1986-10-25       Impact factor: 5.157

10.  Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3.

Authors:  M Miura; H Zhu; R Rotello; E A Hartwieg; J Yuan
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

View more
  6 in total

Review 1.  Chronic rhinosinusitis and sleep: a contemporary review.

Authors:  Jeremiah A Alt; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2013-08-26       Impact factor: 3.858

2.  Administration of intravenous immunoglobulin (IVIG) in vivo--down-regulatory effects on the IL-1 system.

Authors:  P Aukrust; F Müller; M Svenson; I Nordøy; K Bendtzen; S S Frøland
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

Review 3.  NOD-like receptor(s) and host immune responses with Pseudomonas aeruginosa infection.

Authors:  Alaa Alhazmi
Journal:  Inflamm Res       Date:  2018-01-20       Impact factor: 4.575

4.  Effects of a tumor necrosis factor-α antagonist on experimentally induced rhinosinusitis.

Authors:  Dong-Hyun Kim; Eun-Ju Jeon; Shi-Nae Park; Kyung-Ho Park; Yong-Soo Park; Sang Won Yeo
Journal:  J Biomed Biotechnol       Date:  2011-06-09

5.  Host conditioning with IL-1β improves the antitumor function of adoptively transferred T cells.

Authors:  Ping-Hsien Lee; Tori N Yamamoto; Devikala Gurusamy; Madhusudhanan Sukumar; Zhiya Yu; Jane Hu-Li; Takeshi Kawabe; Arunakumar Gangaplara; Rigel J Kishton; Amanda N Henning; Suman K Vodnala; Ronald N Germain; William E Paul; Nicholas P Restifo
Journal:  J Exp Med       Date:  2019-08-12       Impact factor: 14.307

6.  The interleukin-1 beta-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy.

Authors:  I I Singer; S Scott; J Chin; E K Bayne; G Limjuco; J Weidner; D K Miller; K Chapman; M J Kostura
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.